China

Astellas' Anticancer Drug Padoseb Receives Approval in China! New Light for Urothelial Carcinoma Treatment

Current Status and New Treatment Options for Urothelial Carcinoma in China The news that Astellas Pharma Inc. and Pfizer Inc. have approved the anticancer drug Padceb for the treatment of urothelial carcinoma in China is a major step forward in the field of cancer treatment. Urothelial carcinoma is a type of cancer that develops in […]